View Author
Ries, C.
( C. Ries)
pmn-e patient tumor cancer breast prognostic level elastase model inhibitor prognostic factors factor status breast cancer prognostic value analysis protein prognosis breast cancer patients 0.001 multivariate value pmn-e levels plasminogen hazard hazards assumption protease multivariate models urokinase-type plasminogen activator follow-up survival activator leukocyte tissue base model study tumor size month failure relationship spearman rank correlation point analyses polymorphonuclear leukocyte elastase node-negative cytosol polymorphonuclear adjuvant nodal status menopausal status assumption system tumor characteristics yamashita node-positive patients prognostic factor treatment sample metastasi node-positive tumor level breast cancer metastasis serine tumor tissues node-negative patients plasmin cancer inst plasminogen activation function menopausal polymorphonuclear leukocytes multivariate analysis 1- proteinase inhibitor table breast cancer cells pmn-e level free-form elastase protease systems 120 months tumor tissue extracts
1 Most Recent Publications
|
The prognostic value of polymorphonuclear leukocyte elastase in patients with primary breast cancer
(Article)
Foekens, J.A. Ries, C. Look, M.P. Gippner-Steppert, C. Klijn, J.G.M. Jochum, M. |
2003-01-01
|